TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 3 | 5 | 0 | 30 | 61 | 0 | 25 |
| S | %wins | 33 | 33 | 67 | 0 | 0 | 27 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/21 15:37 | 8/17/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Sharon J. | CO | D | S.d | -534 | 266.83 | 0 | -2 | -21 | 8 | D | |||||||||||||||
5/25/21 12:35 | 5/24/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Larson Sharon J. | CO | D | S.d | -615 | 205.00 | 0 | -3 | -29 | 8 | D | |||||||||||||||
8/4/16 17:04 | 11/16/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Riley Sharon L. | CO | D | S | -8 | 8.09 | 4 | -1 | -100 | 0 | D | 251 | 38 | 32 | 38 | 43 | 15 | 14 | 14 | 3 | 7 | 9 | 19 | 67 | ||
5/10/16 16:32 | 5/10/16 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Riley Sharon L. | CO | D | S.d | -184 | 36.87 | 3 | -5 | -53 | 5 | D | 226 | 34 | 14 | 3 | 23 | 34 | 19 | 3 | -1 | 0 | -6 | 33 | 58 | ||
5/9/16 17:14 | 5/5/16 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Riley Sharon L. | CO | D | S.d | -535 | 35.66 | 3 | -15 | -77 | 5 | D | 214 | 32 | 11 | -4 | 27 | 23 | 22 | -2 | 6 | 9 | -3 | 38 | 57 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |